Addictions, Drug & Alcohol Institute

Medication-First Delivery for High-Acuity Opioid Use Disorder Populations

This is a multi-site, replication, implementation study of low-barrier buprenorphine access combined with care navigation to be delivered with community based service providers such as syringe exchanges, mobile medical clinics and homeless services providers.


Caleb Banta-Green, PhD, MPH, MSW PI (UW ADAI)

Fund Information

The Paul G. Allen Family Foundation, Premera Blue Cross, Washington State Health Care Authority Division of Behavioral Health and Recovery
End: December 31, 2022
Status: completed